3 hours Amgen (NASDAQ:AMGN) Price Target Increased to $315.00 by Analysts at Barclays MarketBeat
Barclays raised their price target on Amgen from $300.00 to $315.00 and gave the company an “equal weight” rating in a report on Monday.
Barclays raised their price target on Amgen from $300.00 to $315.00 and gave the company an “equal weight” rating in a report on Monday.